Selective synthesis in mammalian cells of the hepatitis B virus middle surface (MS) protein, which is 55 amino acids longer than the major surface (S) protein, was achieved by using a recombinant vaccinia virus. The 33-kilodalton MS polypeptide was glycosylated and secreted as particles that resembled human hepatitis B surface antigen as well as particles composed solely of S protein with regard to antigenicity, buoyant density, size, and electron micrographic appearance. The MS particles differed from S particles, however, by binding to polymerized human albumin and inducing antibodies that reacted with a pre-S peptide and inhibited the binding of human plasma-derived hepatitis B surface antigen to polymerized human albumin. [LS]) that have the same carboxyl terminus (5, 8, 22) . Disulfide-linked dimers of S polypeptides form the structural unit of the HBV envelope, whereas MS and LS polypeptides may be involved in virus attachment to hepatocytes (7, 15) . The region of the HBV genome that encodes surface proteins contains one long open reading frame that may be divided into pre-Sl, pre-S2, and S regions (23). All three domains compose the coding sequence for the LS polypeptide, whereas the MS polypeptide is encoded by pre-S2 plus S, and the S polypeptide is encoded by S alone. Transcripts with 5' ends that map within or upstream of the pre-S regions have been described previously (3, 6, 10, (17) (18) (19) 21 Construction of MS recombinant vaccinia virus. We prepared a recombinant vaccinia virus (Wyeth strain) that expresses the HBV MS protein by using a protocol (9) that is similar to the one used for construction of recombinants that express S (20) and LS (4) polypeptides. A 1.2-kilobase-pair DNA segment starting 40 base pairs upstream of the pre-S2 translation initiation codon and terminating 250 base pairs downstream of the S coding region of HBV DNA (24) 
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Although HBV cannot replicate in tissue culture cells, synthesis of HBsAg has been obtained by recombinant DNA methods (for a review, see reference 23). Selective expression of S, MS, and LS polypeptides would be desirable for studying the processing and transport as well as the physical and immunological properties of these proteins. However, in mammalian cells, only S or a mixture of S and MS polypeptides (1, 6, 10, 17) has been made. Although selective synthesis of MS has been achieved in yeast (24) , HBsAg particles are not secreted by these lower eucaryotic cells but are obtained after cell disruption. Vaccinia Construction of MS recombinant vaccinia virus. We prepared a recombinant vaccinia virus (Wyeth strain) that expresses the HBV MS protein by using a protocol (9) that is similar to the one used for construction of recombinants that express S (20) and LS (4) Fig. 1B .
As previously reported (20) , S is rapidly detected intracellularly and within a few hours appears in the medium.
Between 8 and 16 h, the level of S in the medium exceeded that in the cells. Secretion of MS particles appeared to occur more slowly so that the amount in the medium did not exceed the amount in the cells until 48 h (Fig. 1C) The purified MS particles were visualized by electron microscopy and appeared identical to human HBsAg (Fig. 1C,  inset) . Previous studies have shown that HBV particles specifically bind to polymerized human albumin and that binding sites are present in the pre-S2-encoded peptide (7, 8, 10, 15, 17) . Fig. 2A and B) . Rabbit (Fig.  3) . This was evidently due to antibody to pre-S2 epitopes since antisera from rabbits inoculated with S recombinant vaccinia virus (Fig. 3) or from unimmunized rabbits (data not shown) did not prevent binding in this assay. Antiserum from a rabbit immunized with an LS recombinant vaccinia virus, however, also blocked binding of HBsAg to polymerized human albumin (Fig. 3) .
Conclusion genic (11, 12, 14) , the inclusion of the MS and LS proteins or peptides derived from them may be desirable in vaccines. Evidence was previously obtained that chimpanzees inoculated with a recombinant vaccinia virus that selectively expressed S were protected from clinical signs of hepatitis after an intravenous challenge with HBV (13) . Rather than stimulating the production of neutralizing antibodies, however, the vaccination primed the animals so that they exhibited a rapid and protective anamnestic response to HBsAg upon HBV challenge. Whether MS or LS recombinant vaccinia viruses provide more complete immunizing effects in primates is currently under investigation.
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